CC
AMGN icon

Cedar Capital’s Amgen AMGN Stock Holding History

Cedar Capital’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,031
Closed -$516K – 60
2020
Q3 		$516K Buy
2,031
+822
+68% +$204K 0.17% 128
2020
Q2 		$285K Sell
1,209
-108
-8% -$24.6K 0.11% 152
2020
Q1 		$267K Sell
1,317
-554
-30% -$121K 0.13% 131
2019
Q4 		$451K Buy
1,871
+334
+22% +$73.6K 0.21% 127
2019
Q3 		$297K Buy
+1,537
New +$295K 0.14% 144
2019
Q1 		– Sell
-1,291
Closed -$251K – 157
2018
Q4 		$251K Sell
1,291
-54
-4% -$10.5K 0.13% 134
2018
Q3 		$279K Buy
+1,345
New +$265K 0.11% 149

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Cedar Capital's AMGN Position: Q4 2020 in Review

Cedar Capital sold out of Amgen (AMGN) in Q4 2020, closing a stake of 2,031 shares — an estimated $516K sold.

Cedar Capital first reported a position in AMGN in Q3 2018 and held it in 7 quarters. The position peaked at $516K in Q3 2020. 2,218 funds tracked by Wall St. Rank hold AMGN as of Q4 2020.

  • Cedar Capital reported no remaining Amgen position as of Q4 2020 after selling out during the quarter.
  • Cedar Capital sold 2,031 Amgen shares in Q4 2020, an estimated $516K.
  • Cedar Capital first reported a position in Amgen in Q3 2018 and held it in 7 quarters.
  • Cedar Capital's Amgen position peaked at $516K in Q3 2020.
  • 2,218 funds tracked by Wall St. Rank held Amgen as of Q4 2020.

Based on Cedar Capital's 13F filing for Q4 2020, filed 5 Feb 2021.